Atypical CLL-like and non-CLL-like MBL were defined based on the occurrence of an unbalanced κ/λ ratio (more than 3∶1 or less than 1∶3) within CD5+ and CD5− B cells, respectively. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.